SCHEMBL1030850

SCHEMBL1030850

CC(=O)c1ccc(-n2c3ccc(C(=O)c4ccccc4C)cc3c3cc(C(=O)c4ccccc4C)ccc32)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
HTT P42858 3/20 0.53
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
MAPT P10636 3/20 0.43
MAPK13 O15264 2/20 0.41
MAPK12 P53778 2/20 0.41
MAPK11 Q15759 2/20 0.41
MAPK14 Q16539 2/20 0.41
HPGD P15428 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40
FFAR1 O14842 1/20 0.40
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
POLB P06746 1/20 0.38
HPD P32754 1/20 0.37
RORC P51449 1/20 0.37
KDM4E B2RXH2 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1031152 0.88 ALDH1A1 (0.49) ALDH1A1HTTMAPTMAPK13MAPK12
SCHEMBL1031154 0.88 ALDH1A1 (0.49) ALDH1A1HTTMAPTMAPK13MAPK12
SCHEMBL27936271 0.84 ALDH1A1 (0.48) ALDH1A1HTTMAPTMAPK13MAPK12
SCHEMBL31145039 0.84 ALDH1A1 (0.63) ALDH1A1HTTMEN1KMT2AMAPT
SCHEMBL626556 0.84 ALDH1A1 (0.63) ALDH1A1HTTMEN1KMT2AMAPT
SCHEMBL13300260 0.84 ALDH1A1 (0.46) ALDH1A1HTTMEN1KMT2AMAPT
SCHEMBL1032916 0.82 ALDH1A1 (0.52) ALDH1A1HTTMEN1KMT2AMAPT
SCHEMBL27936272 0.82 ALDH1A1 (0.46) ALDH1A1HTTMEN1KMT2AMAPK13
SCHEMBL3333365 0.81 CNR2 (0.52) ALDH1A1HTTMEN1KMT2AMAPT
SCHEMBL3021403 0.81 ALDH1A1 (0.54) ALDH1A1HTTMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8940464-B2 Oxime ester photoinitiators BASF SE (DE) 2015-01-27 US disclosed
EP-2172455-B1 Oxime ester photoinitiators BASF SE (DE) 2011-01-19 EP disclosed
EP-2172455-A1 Oxime ester photoinitiators BASF SE (DE) 2010-04-07 EP disclosed
US-20090087759-A1 Oxime Ester Photoinitiators BASF SE (DE) 2009-04-02 US disclosed
EP-1957457-A1 OXIME ESTER PHOTOINITIATORS Ciba Holding Inc. (CH) 2008-08-20 EP disclosed
WO-2007062963-A1 OXIME ESTER PHOTOINITIATORS CIBA HOLDING INC. (CH) 2007-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090087759-A1 Oxime Ester Photoinitiators CBR3, CCNE2, ALKBH2 ALDH1A1 1219/4885HTT 3395/4885MEN1 4410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.